Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol in Hysteroscopic Myomectomy
NCT06049745Phase 4Not yet recruiting
- Sponsor
- Assuta Ashdod Medical Center
- Start
- Nov 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of misoprostol in Uterine Fibroids (UF) (2 arms), sponsored by Assuta Ashdod Medical Center. Primary endpoint: length of the procedure. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT06049745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06049745.